About

About Genomics Genomics is a science-led transatlantic TechBio combining large-scale genetic and health data with proprietary analytics to accelerate drug discovery and advance predictive, preventative healthcare. Spun out of the University of Oxford in 2014 by the world’s top statistical and human geneticists, the company is built on a decade of world-class science and R&D. Its mission is to help people lead longer, healthier lives. Genomics is a precision medicine company accelerating target discovery and clinical development through large-scale genomic insights powered by AI/ML-driven analysis. We were formed in 2014 by four ground-breaking statistical and human geneticists at the University of Oxford. Today, we are collaborating with some of the world’s leading innovators in drug development, enabling them to leverage genomics to de-risk decision making, identify and validate targets, improve trial success rates, and reduce trial time-to-completion. Our cutting-edge solutions support the advancement of groundbreaking therapies, enabling our partners to accelerate the discovery and commercialisation of next-generation treatments.